Plasminogen activator inhibitor-1 deficiency protects against atherosclerosis progression in the mouse carotid artery

Blood

Volumn 96, Issue 13, 2000, Pages 4212-4215

  Eitzman, Daniel T ^a   Westrick, Randal J ^b   Xu, Zuojun ^b   Tyson, Julia ^b   Ginsburg, David ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; FIBRIN; FIBRINOGEN; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ANIMAL; AORTA DISEASE; ARTERIOSCLEROSIS; ARTICLE; BLOOD RHEOLOGY; CAROTID ARTERY DISEASE; CAROTID ARTERY INJURY; CAROTID ARTERY OBSTRUCTION; CHEMISTRY; COMMON CAROTID ARTERY; DISEASE COURSE; GENETICS; MALE; MOUSE; MOUSE MUTANT; PATHOLOGY; PHOTOCHEMISTRY; PHYSIOLOGY; THORACIC AORTA;

ANIMALS; AORTA, THORACIC; AORTIC DISEASES; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; CAROTID ARTERY DISEASES; CAROTID ARTERY INJURIES; CAROTID ARTERY, COMMON; CAROTID STENOSIS; DISEASE PROGRESSION; FIBRIN; FIBRINOGEN; HEMORHEOLOGY; MALE; MICE; MICE, KNOCKOUT; PHOTOCHEMISTRY; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1;

EID: 0034672348     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.13.4212     Document Type: Article

References (19)

1. Ross R. The palhogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
2. Bini A, Fenoglio JJ Jr, Mesa-Tejada R, Kudryk B, Kaplan KL. Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis. Use of monoclonal antibodies. Arteriosclerosis. 1989;9:109-121.
3. Schwartz CJ, Valente AJ, Kelley JL, Sprague EA, Edwards EH. Thrombosis and the development of atherosclerosis: Rokitansky revisited. Semin Thromb Haemost. 1988;14:189-195.
4. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 1984;311:501-505.
5. Loskutoff DJ. A slice of PAI. J Clin Invest. 1993;92:2563.
6. Hamsten A, Wiman B, de Faire U, Blomback M. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med. 1985;313:1557-1563.
7. Plump AS, Smith JD, Hayek T, et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 1992;71:343-353.
8. Zhang SH, Reddick RL, Piedrahita JA, Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 1992;258:468-471.
9. Ishibashi S, Goldstein JL, Brown MS, Herz J, Burns DK. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J Clin Invest.1994;93:1885-1893.
10. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb Vasc Biol. 1994;14:133-140.
11. Ding Z, Biggs T, Seed WA, Friedman MH. Influence of the geometry of the left main coronary artery bifurcation on the distribution of sudanophilia in the daughter vessels. Arterioscler Thromb Vasc Biol.1997;17:1356-1360.
12. Xiao Q, Danton M, Witte DP, et al. Plasminogen deficiency accelerates vessel wall disease in mice predisposed to atherosclerosis. Proc Natl Acad Sci USA. 1997;94:10335-10340.
13. Xiao Q, Danton MJ, Witte DP, Kowala MC, Valentine MT, Degen JL. Fibrinogen deficiency is com-patible with the development of atherosclerosis in mice. J Clin Invest. 1993;101:1184-1194.
14. Carmeliet P, Kieckens L, Schoonjans L, et al. Plasminogen activator inhibitor-1 gene-deficient mice, I. Generation by homologous recombination and characterization. J Clin Invest. 1993;92:2746-2755.
15. Sjoland H, Eitzman DT, Gordon D, Westrick RJ, Nabel EG, Ginsburg D. Atherosclerosis progression in LDL receptor deficient and apolipoprotein E deficient mice is independent of genetic alterations in plasminogen activator inhibitor-1. Arterioscler Thromb Vasc Biol. 2000;20:846-852.
16. Eitzman DT, Westrick RJ, Xu Z, Tyson J, Ginsburg D. Hyperlipidemia promotes thrombosis following injury to atherosclerotic vessels in apolipoprotien E deficient mice. Arterioscler Thromb Vasc Biol. 2000;20:1831-1834.
17. Eitzman DT, Westrick RJ, Nabel EG, Ginsburg D. Plasminogen activator inhibitor-1 and vitronectin promote vascular thrombosis in mice. Blood. 2000;95:577-580.
18. DeWood MA, Stifter WF, Simpson CS, et al. Coronary arteriographic findings soon after non-Q-wave myocardial infarction. N Engl J Med. 1986;315:417-423.
19. Olofsson BO, Dahlen G, Nilsson TK. Evidence for increased levels of plasminogen activator inhibitor and tissue plasminogen activator in plasma of patients with angiographically verified coronary artery disease. Eur Heart J. 1989;10:77-82.